Treace Medical (TMCI) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Hold | $5.00 from $4.00 | Aug 10, 2026 |
| Truist Securities | Maintained | Hold | $4.00 from $2.00 | Jul 16, 2026 |
| Lake Street | Maintained | Buy | $7.00 from $7.50 | Mar 2, 2026 |
| Stifel | Maintained | Hold | $3.00 from $5.00 | Jan 7, 2026 |
| Truist Securities | Maintained | Hold | $3.00 from $4.00 | Dec 18, 2025 |
| Truist Securities | Maintained | Hold | $4.00 from $7.00 | Nov 10, 2025 |
| BTIG | Downgraded | Buy → Neutral | — | Nov 7, 2025 |
| JP Morgan | Downgraded | Neutral → Underweight | $5.00 from $8.00 | Nov 7, 2025 |
| UBS | Maintained | Neutral | $5.85 from $6.50 | Nov 7, 2025 |
| Truist Securities | Maintained | Hold | $7.00 from $8.00 | Oct 15, 2025 |
| Truist Securities | Maintained | Hold | $8.00 from $6.60 | Sep 4, 2025 |
| Stifel | Maintained | Hold | $6.00 from $9.00 | Aug 8, 2025 |
| UBS | Maintained | Neutral | $6.50 from $8.60 | Aug 8, 2025 |
| UBS | Maintained | Neutral | $8.60 from $10.00 | May 9, 2025 |
| Truist Securities | Maintained | Hold | $8.00 from $9.50 | Apr 11, 2025 |
| Truist Securities | Maintained | Hold | $9.50 from $10.00 | Mar 13, 2025 |
| Truist Securities | Maintained | Hold | $10.00 from $8.40 | Mar 3, 2025 |
| Lake Street | Initiated Coverage | Buy | $14.50 | Dec 31, 2024 |
| Truist Securities | Maintained | Hold | $8.40 from $7.00 | Dec 18, 2024 |
| JP Morgan | Initiated Coverage | Neutral | $8.00 | Dec 17, 2024 |
Frequently asked questions
Is TMCI a buy, sell, or hold?
Analysts covering Treace Medical currently average a Hold rating: 1 buy, 3 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on TMCI?
On Aug 10, 2026, Truist Securities maintained Treace Medical at Hold with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.